Prescription Drugs: Expanding Access to Federal Prices Could Cause Other Price Changes

HEHS-00-118 Published: Aug 07, 2000. Publicly Released: Sep 06, 2000.
Jump To:
Skip to Highlights

Pursuant to a congressional request, GAO provided information on the expansion of Medicare beneficiaries' access to prescription drugs, focusing on the: (1) federal drug price discounts available to federal and nonfederal purchasers and the size of those discounts; and (2) potential effects that extending such discounts to nonfederal purchasers may have on outpatient drug prices paid by federal and nonfederal purchasers.

Full Report